Peripheral nerve block for painful diabetic neuropathy
Official title: Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy: How Important is the Peripheral Signaling?
Run by University of Aarhus · NCT04699734 · Data updated 2026-11-12
This study is testing if a nerve block can help adults with painful diabetic neuropathy feel less pain without stopping their regular medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Aarhus N, Jutland) |
| Status | Recruiting |
| Started | September 8, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 7, 2021 |
| Trial ID | NCT04699734 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with confirmed painful diabetic neuropathy and a pain intensity rating above 4 on the NRS scale.
✕Probably not a fit
Patients with other identifiable causes of pain, severe psychiatric conditions, or contraindications to regional anesthesia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a peripheral regional nerve block in relieving spontaneous pain associated with painful diabetic polyneuropathy. It aims to understand the role of peripheral afferent input in pain generation by administering Xylocaine 1% and NaCl to participants. The study includes adults aged 18 and older who have confirmed diabetic neuropathy and have experienced neuropathic pain for at least six months. Participants will not need to discontinue their pain medications during the study.
Why it matters
Potential benefit: If successful, this approach could significantly alleviate pain for patients suffering from diabetic neuropathy.
How similar studies have gone: While similar approaches have been explored, the specific application of peripheral nerve blocks for this condition remains novel and under-researched.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years or older. * Probably diabetic neuropathy confirmed using the Toronto criteria in a "conservative manner", i.e. three out of three symptoms/signs of neuropathy must be present (sensory neuropathy symptoms, distal reduced sensibility, reduced ankle reflexes) 7. * Definite or probable neuropathic pain for minimum the last 6 months * Mean pain intensity at \> 4 NRS the last week17. Since we expect a large effect of the block it is not necessary to discontinue pain medication. Exclusion Criteria: * Other causes of pain in the same area or other pain that cannot be distinguished from the neuropathic pain. * Unable to understand and speak Danish. * Non-cooperative. * Warfarin or other medication that contraindicate regional anesthesia. * Infection in the injection area. * Allergy to lidocaine. * Pregnancy or lactating (fertile women must to show negative pregnancy test or use anticonception). * Severe psychiatric disease e.g. severe depression during the last 6 months. * Alcohol or drug abuse.
Where it's running
-
Danish Pain Research Center, Aarhus University, Aarhus University Hospital
Aarhus N, Jutland, Denmark Recruiting
Study contacts
- Principal investigator: Ellen L Schaldemose, MD — Danish Pain Research Center, Aarhus University
- Study coordinator: Ellen L Schaldemose, MD
- Email: ells@clin.au.dk
- Phone: +45 93501942
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-use Erchonia EVRL laser for temporary relief of idiopathic peripheral neuropathy foot pain
This study will test whether a home-use Erchonia EVRL laser can provide temporary relief of foot pain for adults with idiopathic peripheral neuropathy.
-
Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer
This study will test whether levels of tiny blood molecules called microRNAs can predict how often and how badly patients with lung or colorectal cancer get nerve damage from certain chemotherapies.
-
Feasibility of paired non-invasive blood flow and tissue oxygen monitoring to detect limb ischemia during lithotomy-position surgeries
This study tests whether using combined non-invasive blood flow monitoring and tissue oxygen sensors during long lithotomy surgeries can help detect early limb ischemia in adults.
-
Using neuromodulation to treat pain from chemotherapy-induced peripheral neuropathy
This study is testing a new way to relieve pain from nerve damage caused by chemotherapy in patients with lower extremity CIPN.
-
Electrical stimulation to improve recovery after cubital tunnel surgery
This study is testing a new electrical stimulation treatment to see if it helps people recover better after surgery for cubital tunnel syndrome.
-
Using a smartphone app to track pain and mood changes
This study is testing a smartphone app to track pain and mood changes in people with chronic pain and healthy individuals to see how these factors affect pain over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.